.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Workshop

Workshop 4
Viral vectors and vaccines II

Termin

Datum: 04.03.2025

Zeit: 17:45 – 19:15

Ort / Stream:

Audimax II

Chair

Programm

17:45 – 18:00 12 Min. 3 Min.
Abstract talk
O 017
Combination of therapeutic vaccination with in vivo stimulation of 4-1BB signaling boosts the immune response against hepatitis B virus in high-titer HBV-carrier mice
Dr. Anna Kosinska (Neuherberg (Munich) / DE)
Viral vectors and vaccines
18:00 – 18:15 12 Min. 3 Min.
Abstract talk
O 018
Influenza vector-based defective interfering particles for use as broad-spectrum antiviral and mucosal live vaccine: construction, production and in vivo efficacy
Dr. Sascha Y. Kupke (Magdeburg / DE)
Viral vectors and vaccines
18:15 – 18:30 12 Min. 3 Min.
Abstract talk
O 019
Stabilization of the native conformation of class I viral fusion proteins by destabilizing the postfusion six-helix bundle
Debajyoti Chakraborty (Bengaluru / IN)
Viral vectors and vaccines
18:30 – 18:45 12 Min. 3 Min.
Abstract talk
O 020
Analysis of Cross-Neutralizing Antibodies between Different Human Papillomavirus Genotypes
Jonas Koch (Innsbruck / AT)
Viral vectors and vaccines
18:45 – 19:00 12 Min. 3 Min.
Abstract talk
O 021
Inducing mucosal antibody responses against HIV-1 by intrastructural help (ISH) using virus-like particle (VLP) vaccine
Caroline Rolfes (Erlangen / DE)
Viral vectors and vaccines
19:00 – 19:15 12 Min. 3 Min.
Abstract talk
O 022
Modified Vaccinia virus Ankara-based vaccine candidate provides cross-protection against lethal MARV challenge in a single-dose vaccination regimen
Dr. Alexandra Kupke (Marburg / DE)
Viral vectors and vaccines

Workshop 4Viral vectors and vaccines II

Termin

Chair

Programm

Workshop 4
Viral vectors and vaccines II